AGP Picks
View all

NDH Fund makes first investment in ELMNT IR

New Dimensions Health Fund has backed ELMNT IR, an outpatient interventional radiology company operating in Southern California. The deal marks NDH Fund’s first investment and signals its move into healthcare services, digital health, healthcare IT and healthcare AI. Why it matters: - NDH Fund’s first investment signals the start of capital deployment into healthcare companies the firm expects to scale. - ELMNT IR is aiming to shift interventional radiology into outpatient settings at scale, which could lower costs and broaden access for patients and referring physicians. - The model reflects a broader move toward less invasive care in ambulatory settings as technology advances. What happened: - New Dimensions Health Fund announced its first investment in ELMNT IR on June 11, 2026. - ELMNT IR is a multi-site outpatient interventional radiology company operating in Southern California. - Steven Yecies, Founder and Managing Partner of NDH Fund, co-founded ELMNT IR. - NDH Fund described the investment as an early step in its strategy to back high-growth healthcare services, digital health, healthcare IT and healthcare AI companies. The details: - ELMNT IR says its outpatient model improves access, clinical quality and patient experience while reducing the cost of services. - The company says it is building the first meaningful multisite, multistate outpatient interventional radiology provider. - ELMNT IR is headquartered in Los Angeles. - NDH Fund is a private investment firm focused on $50 million to $250 million investments in early-stage and growth-oriented healthcare services and healthcare IT companies. - The firm says it partners with founders and management teams by providing capital, industry access and help building growth capabilities. - Yecies has completed more than 50 prior investments and previously worked at OrbiMed Advisors, Kain Capital, Chronic Health Capital and Spanos & Yecies. - Jonathan Steinberger, MD, is co-founder and chief medical officer of ELMNT IR. - Steinberger said NDH resources and Yecies’ experience and relationships can help ELMNT IR grow and reach the potential of outpatient interventional radiology. Between the lines: - The investment ties NDH Fund directly to a company co-founded by its own managing partner, giving the firm a proprietary entry point into the business. - ELMNT IR’s pitch is not just medical. It is operational and financial, centered on shifting procedures out of higher-cost inpatient settings. - NDH Fund appears to be positioning itself as a specialist investor in care delivery models that can be scaled with technology and lower-cost infrastructure. - LinkedIn profile provides Steven Yecies’ public professional page. What’s next: - ELMNT IR is likely to use the new investment to support growth across its Southern California footprint and potentially expand into additional markets. - NDH Fund is expected to continue deploying capital into healthcare services and technology companies as it builds its portfolio. - The companies are betting that outpatient interventional radiology can win share from traditional inpatient care by offering lower prices and easier access.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.